PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Novel Strategies for Chronic Kidney Disease: New Data, New Paradigm?
Visit https://www.peervoice.com/YPT860 to view the entire programme with slides. After completing “Novel Strategies for Chronic Kidney Disease: New Data, New Paradigm?”, participants will be able to: Summarise key finding from a published study evaluating an SGLT2 inhibitor for the management of CKD; Discuss the strengths and limitations of this study in light of current practices for the management of CKD; and Describe the impact of these data on clinical practice within the context of current and future treatment paradigms for CKD with or without diabetes.